Memorial Sloan Kettering Cancer Center Fundamentals and Advances in Immunotherapy in the Oncology Patient 2024
Format: 23 videos + 1 pdf, size: 5.44 GB
Course Audience: physicians, and nurses who care for oncology patient
Overview:
Date & Location
Wednesday, January 24, 2024, 8:00 AM – 5:20 PM, Online, New York , NY
Specialties
Specialties – Allergy and Immunology, Bone Marrow Transplant, Breast Medical Oncology, Cellular Therapeutics, Critical Care, Dermatology, Endocrinology, Diabetes and Metabolism, Gastrointestinal Oncology, Genitourinary Oncology, Gynecologic Oncology, Head and Neck Oncology, Hepatology, Hospice and Palliative Medicine, Immunotherapy, Leukemia, Lymphoma, Medical Oncology, Neurology, Neuro-Oncology, Nurse Practitioner, Nursing, Oncology and Hematology, Pharmacology and Medication Management, Physician Assistant, Pulmonary Medicine, Radiation Oncology, Rheumatology, Solid Tumor Oncology
Overview
Immunotherapeutics has changed the landscape of treatment modalities available to the cancer patient in both solid tumor and hematologic malignancies. Since the breakthrough of ipilimumab, there have been fast-paced and ongoing advancements in the field of immunotherapy, revolutionizing clinical management at a rapid pace.
This one-day virtual symposium will review fundamental concepts and recent advances in immunotherapy designed to meet the learning needs of advanced practice providers (APPs) and other allied health professionals. Clinical application in solid tumor and hematologic malignancies will be discussed as well as toxicity management, including immune-related adverse events resulting from immune checkpoint inhibition.
Experts will discuss the fundamentals of immune checkpoint blockade and CAR T cell therapy, as well as advancements in TIL and BITE therapy, novel combination therapy, and algorithmic management of immune-related adverse events. Toxicity management will be communicated through case study applications and demonstration of common, rare, and severe immune-related adverse events.
The overall goal of this program is to improve cancer patient outcomes by advancing the science, development, and application of cancer immunology and immunotherapy through fundamental understanding and clinical application.
Attendees of this symposium will receive access to an online syllabus, which includes select video recordings of the lectures.
Target Audience
The target audience for this course includes nurse practitioners, physician assistants, certified registered nurse anesthetists, physicians, and nurses who care for oncology patient.
Objectives
At the conclusion of this symposium, learners will be able to:
- Describe the principles surrounding the immunity cycle
- Explain fundamental principles of immunotherapeutic agents including immune checkpoint inhibition, CAR T cell, TIL, and BITE therapies.
- Discuss the symptoms of Cytokine release Syndrome, ICANS, prolonged cytopenias and clinical management
- Recognize and identify common, rare, and severe immune related adverse events attributed to immune checkpoint inhibition
- Discuss clinical application of immune modulated agents in the oncology population
APPImmuno2024_Brochure (PDF Format)
Arthralgias and Myalgias (Video MP4 Format)
Benefit of Adjuvant Combination Therapy vs. Surveillance in High Risk Hepatocellular Carcinoma Patients (Video MP4 Format)
Clinical Landscape of Immunotherapy in Soft Tissue Sarcoma- Fundamentals and Advances in Immunotherapy (Video MP4 Format)
Dermatologic irAEs (Video MP4 Format)
FDA Approved CAR T Products in the Treatment and Management of Leukemia (Video MP4 Format)
Fundamentals of Chimeric Antigen Receptor (CAR) T Cell Immunotherapy (Video MP4 Format)
Hepatotoxicty (Video MP4 Format)
Immunotherapy and CAR T Cell Therapy in Hematologic Malignancies Lymphoma (Video MP4 Format)
Immunotherapy Induced Diabletes Mellitus (Video MP4 Format)
Implementation of Cellular Therapy in the Solid Tumor Population- The Use of TIL Therapy in Melanoma (Video MP4 Format)
Mechanism of Action of Checkpoint Blockade With a Focus on PD1, PDL1, and CTLA-4 (Video MP4 Format)
Neoadjuvant Combination Modalites in Resectable Non Small Cell Lung Cancer (Video MP4 Format)
Novel Checkpoint Inhibitors and Combination Therapy in the Clinical Setting (Video MP4 Format)
Novel Immune Modulated Agents in the Treatment of Glioblastoma (Video MP4 Format)
Overall Survival (OS) in Recurrent or Metastatic Cervical Cancer Using Combination Therapy (Video MP4 Format)
Overview of Adverse Events in the Cellular Therapy Patient- CRS, ICANS, and Prolonged Cytopenias (Video MP4 Format)
Panel Discussion- Clinical Application of Immune Checkpoint Inhibitors in Solid Tumor Malignancy (Video MP4 Format)
Panel Discussion- Clinical Application of Immune Therapy in Hematologic Malignancy (Video MP4 Format)
Panel Discussion- Clinical Updates in Solid Tumor and Novel Immune Modulation (Video MP4 Format)
Panel Discussion- Diagnosis and Clinical Management of Immune Related Adverse Events (irAE) (Video MP4 Format)
Panel Discussion- Fundamentals of T Cell Therapy (Video MP4 Format)
Pneumonitis (Video MP4 Format)
T Cell Re-Directing Therapy in Multiple Myeloma (Video MP4 Format)